Learn more

VEGENICS LTD

Overview
  • Total Patents
    48
About

VEGENICS LTD has a total of 48 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GILEAD BIOLOGICS INC, PRODA BIOTECH LLC and ALEXION PHARMA INC.

Patent filings in countries

World map showing VEGENICS LTDs patent filings in countries
# Country Total Patents
#1 United States 28
#2 Australia 8
#3 WIPO (World Intellectual Property Organization) 7
#4 EPO (European Patent Office) 5

Patent filings per year

Chart showing VEGENICS LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Alitalo Kari 29
#2 Achen Marc G 15
#3 Stacker Steven 10
#4 Stacker Steven Alan 7
#5 Achen Marc 7
#6 Wilks Andrew F 5
#7 Stacker Steven A 5
#8 Joukov Vladimir 5
#9 Tammela Tuomas 4
#10 Mccoll Bradley 4

Latest patents

Publication Filing date Title
WO2010111746A1 Anti-vegf-d antibodies
WO2010078624A1 Materials and methods for the treatment of hypertension
WO2010065995A1 Isolated vegf-c and vegf-d peptides and uses thereof
US2011142839A1 Treatment of pulmonary edema
US2009017011A1 Modulation of vegf-c/vegfr-3 interactions in the treatment of rheumatoid arthritis
US2008267924A1 Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery
AU2006201128A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor D
AU2005244958A1 Method for inhibiting angiogenesis and/or lymphangiogenesis
US7727761B2 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
US2005202015A1 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
AU2002329287B2 Neuropilin/VEGF C/VEGFR 3 materials and methods
US7611711B2 VEGFR-3 inhibitor materials and methods